Skip to main content

Advertisement

Log in

Severe infections in systemic lupus erythematosus: disease pattern and predictors of infection-related mortality

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Infection is a major cause of morbidity and mortality among patients with systemic lupus erythematosus (SLE). To describe the pattern of serious infections in patients with SLE and to identify the predictors of infection-related mortality among SLE patients with serious infections, we prospectively studied all SLE patients who were hospitalized with infections in Sarawak General Hospital during 2011–2015. Demographic data, clinical features, and outcomes were collected. Cox regression analysis was carried out to determine the independent predictors of infection-related mortality. There were a total of 125 patients with 187 episodes of serious infections. Our patients were of multiethnic origins with female predominance (89.6%). Their mean age was 33.4 ± 14.2 years. The patients had a mean disease duration of 66.8 ± 74.0 months. The most common site of infection was pulmonary (37.9%), followed by septicemia (22.5%). Gram-negative organisms (38.2%) were the predominant isolates within the cohort. There were 21 deaths (11.2%) during the study period. Independent predictors of infection-related mortality among our cohort of SLE patients were flare of SLE (HR 3.98, CI 1.30–12.21) and the presence of bacteremia (HR 2.54, CI 0.98–6.59). Hydroxychloroquine was protective of mortality from serious infections (HR 9.26, CI 3.40–25.64). Pneumonia and Gram-negative organisms were the predominant pattern of infection in our SLE cohort. The presence of flare of SLE and bacteremia were independent prognostic predictors of infection-related mortality, whereas hydroxychloroquine was protective of infection-related mortality among SLE patients with serious infections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lee J, Dhillon N, Pope J (2013) All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre. Rheumatology (Oxford) 52:905–909

    Article  Google Scholar 

  2. Feldman CH, Hiraki LT, Winkelmayer WC, Marty FM, Franklin JM, Kim SC, Costenbader KH (2015) Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis. Arthritis Rheumatol 7(6):1577–1585

    Article  Google Scholar 

  3. Goldblatt F, Chambers S, Rahman A, Isenberg DA (2009) Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus 18:682–689

    Article  PubMed  CAS  Google Scholar 

  4. Gladman DD, Hussain F, Ibanez D, Urowitz MB (2002) The nature and outcome of infection in systemic lupus erythematosus. Lupus 11:234–239

    Article  PubMed  CAS  Google Scholar 

  5. Petri M, Genovese M (1992) Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins lupus cohort. J Rheumatol 19:1559–1565

    PubMed  CAS  Google Scholar 

  6. Chen D, Xie J, Chen H, Yang Y, Zhan Z, Liang L, Yang X (2016) Infection in southern Chinese patients with systemic lupus erythematosus: spectrum, drug resistance, outcomes, and risk factors. J Rheumatol 43(9):1650–1656

    Article  PubMed  CAS  Google Scholar 

  7. Alarcon GS, Jr MGG, Bastian HM, Roseman J, Lisse J, Fessler BJ et al (2001) For the LUMINA study Group Systemic lupus erythematosus in three ethnic groups. VIII. Predictors of early mortality in the LUMINA cohort. Arthritis Rheum 45:191–202

    Article  PubMed  CAS  Google Scholar 

  8. Dubula T, Mody GM (2015) Spectrum of infections and outcome among hospitalized south Africans with systemic lupus erythematosus. Clin Rheumatol 34(3):479–488

    Article  PubMed  Google Scholar 

  9. Ruiz-Irastorza G, Olivares N, Ruiz-Arruza I, Martinez-Berriotxoa A, Egurbide MV, Aguirre C (2009) Predictors of major infections in systemic lupus erythematosus. Arthritis Res Ther 11:R109

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Tektonidou MG, Wang Z, Dasgupta A, Ward MM (2015) Burden of serious infections in adults with systemic lupus erythematosus: a National Population-Based Study, 1996–2011. Arthritis Care Res 67(8):1078–1085

    Article  Google Scholar 

  11. Yurkovich M, Vostretsova K, Chen W, Avina-Zubieta JA (2014) Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res 66:608–616

    Article  Google Scholar 

  12. Tan EM, Cohen AS, Fries JF, Masi AT, Mcshane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277

    Article  PubMed  CAS  Google Scholar 

  13. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) The committee on prognosis studies in SLE. The development and validation of the SLE disease activity index (SLEDAI). Arthritis Rheum 35:630–640

    Article  PubMed  CAS  Google Scholar 

  14. Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH et al (2005) The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 142:953–962

    Article  PubMed  CAS  Google Scholar 

  15. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Sanchez-Guerrero J, Urowitz M, Bacon P, Bombardieri S, Hanly J, Jones J, Hay E, Symmons D, Isenberg D, Kalunion K, Maddison P, Nived O, Sturfelt G, Petri M, Richter M, Snaith M, Zoma A (1996) The development and initial validation of the SLICC/ACR damage index for SLE. Arthritis Rheum 39:363–369

    Article  PubMed  CAS  Google Scholar 

  16. Lim E, Koh WH, Loh SF, Lam MS, Howe HS (2001) Nonthyphoidal salmonellosis in patients with systemic lupus erythematosus. A study of fifty patients and a review of the literature. Lupus 10:87–92

    Article  PubMed  CAS  Google Scholar 

  17. Gerona JG, Navarra SV (2009) Salmonella infections in patients with systemic lupus erythematosus: a case series. Int J Rheum Dis 12(4):319–323

    Article  PubMed  Google Scholar 

  18. Yun JE, Lee SW, Kim TH, Jun JB, Jung S, Bae SC, Kim TY, Yoo DH (2002) The incidence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea. Clin Exp Rheumatol 20:127–132

    PubMed  CAS  Google Scholar 

  19. Sayarlioglu M, Inanc M, al KS (2004) Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization. Lupus 13:274–278

    Article  PubMed  CAS  Google Scholar 

  20. Lim CC, Liu PY, Tan HZ, Lee P, Chin YM, Mok IY, Chan CM, Choo JC (2016) Severe infections in patients with lupus nephritis treated with immunosuppressants: a retrospective cohort study. Nephrology

  21. Hellmann DB, Petri M, Whiting-O’Keefe Q (1987) Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine (Baltimore) 66(5):341–348

    Article  CAS  Google Scholar 

  22. Zonana-Nacach A, Yañez P, Jiménez-Balderas FJ, Camargo-Coronel A (2007) Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus. Lupus 16(12):997–1000

    Article  PubMed  CAS  Google Scholar 

  23. Paton NI, Cheong IK, Kong NC, Segasothy M (1996) Risk factors for infection in Malaysian patients with systemic lupus erythematosus. QJM 89(7):531–538

    Article  PubMed  CAS  Google Scholar 

  24. Bosch X, Guilabert A, Pallares L et al (2006) Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus 15:584–589

    Article  PubMed  CAS  Google Scholar 

  25. Rúa-Figueroa Í, López-Longo J, Galindo-Izquierdo M, Calvo-Alén J, Del Campo V, Olivé-Marqués A et al (2017) Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus. Semin Arthritis Rheum

  26. Chen MJ, Tseng HM, Huang YL, Hsu WN, Yeh KW, Wu TL, See LC, Huang JL (2008) Long-term outcome and short-term survival of patients with systemic lupus erythematosus after bacteraemia episodes: 6-yr follow-up. Rheumatology (Oxford) 47:1352–1357

    Article  Google Scholar 

  27. Marcos M, Fernández C, Soriano A, Fernández C, Soriano À, Marco F, Martínez JA, Almela M, Cervera R, Mensa J, Espinosa G (2011) Epidemiology and clinical outcomes of bloodstream infections among lupus patients. Lupus 20:965–971

    Article  PubMed  CAS  Google Scholar 

  28. Feldman CH, Marty FM, Winkelmayer WC, Guan H, Franklin JM, Solomon DH, Costenbader KH, Kim SC (2017) Comparative rates of serious infections among patients with systemic lupus erythematosus receiving immunosuppressive medications. Arthritis Rheumatol 69(2):387–397

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Herrinton LJ, Liu L, Goldfien R, Michaels MA, Tran TN (2016) Risk of serious infection for patients with systemic lupus erythematosus starting glucocorticoids with or without antimalarials. J Rheumatol 43(8):1503–1509

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge the support of the Ministry of Health, Malaysia, for the technical support of the study.

Author information

Authors and Affiliations

Authors

Contributions

All authors were in involved in conception or design, or analysis and interpretation of data, or both. All authors approved the final version of the manuscript.

Corresponding author

Correspondence to C. L. Teh.

Ethics declarations

Disclosures

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teh, C.L., Wan, S.A. & Ling, G.R. Severe infections in systemic lupus erythematosus: disease pattern and predictors of infection-related mortality. Clin Rheumatol 37, 2081–2086 (2018). https://doi.org/10.1007/s10067-018-4102-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-018-4102-6

Keywords

Navigation